Ana Igea

Pamplona, NC, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Immunogenicity of neoantigens from hepatocellular carcinoma patients treated with a combined radioimmunotherapy.

Immunogenicity of neoantigens from hepatocellular carcinoma patients treated with a combined radioimmunotherapy.

Journal: Oncoimmunology
Published: March 19, 2026

Targeting PD-1+ T cells with small-format immunocytokines enhances IL-12 antitumor activity.

Targeting PD-1+ T cells with small-format immunocytokines enhances IL-12 antitumor activity.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 02, 2024

Editorial: Infectious disease agents and cancer.

Editorial: Infectious disease agents and cancer.

Journal: Frontiers in cell and developmental biology
Published: February 19, 2024

Diagnostic Challenges during Inflammation and Cancer: Current Biomarkers and Future Perspectives in Navigating through the Minefield of Reactive versus Dysplastic and Cancerous Lesions in the Digestive System.

Diagnostic Challenges during Inflammation and Cancer: Current Biomarkers and Future Perspectives in Navigating through the Minefield of Reactive versus Dysplastic and Cancerous Lesions in the Digestive System.

Journal: International journal of molecular sciences
Published: December 19, 2023

Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies.

Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies.

Journal: British journal of cancer
Published: June 19, 2023

Characterization of p38α autophosphorylation inhibitors that target the non-canonical activation pathway.

Characterization of p38α autophosphorylation inhibitors that target the non-canonical activation pathway.

Journal: Nature communications
Published: October 19, 2022

Local delivery of optimized nanobodies targeting the PD-1/PD-L1 axis with a self-amplifying RNA viral vector induces potent antitumor responses.

Local delivery of optimized nanobodies targeting the PD-1/PD-L1 axis with a self-amplifying RNA viral vector induces potent antitumor responses.

Journal: Cancer letters
Published: August 30, 2022

Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer.

Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer.

Journal: Frontiers in immunology
Published: July 04, 2022

Combined Inhibition of FOSL-1 and YAP Using siRNA-Lipoplexes Reduces the Growth of Pancreatic Tumor.

Combined Inhibition of FOSL-1 and YAP Using siRNA-Lipoplexes Reduces the Growth of Pancreatic Tumor.

Journal: Cancers
Published: May 17, 2022

MK2 degradation as a sensor of signal intensity that controls stress-induced cell fate.

MK2 degradation as a sensor of signal intensity that controls stress-induced cell fate.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 17, 2021

Editorial: Reprogramming Stromal Cells in Chronic Inflammation and Cancer.

Editorial: Reprogramming Stromal Cells in Chronic Inflammation and Cancer.

Journal: Frontiers in cell and developmental biology
Published: June 21, 2021

Central Role of Semaphorin 3B in a Serum-Induced Arthritis Model and Reduced Levels in Patients With Rheumatoid Arthritis.

Central Role of Semaphorin 3B in a Serum-Induced Arthritis Model and Reduced Levels in Patients With Rheumatoid Arthritis.

Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: October 19, 2020
Showing 1-12 of 29

Last Updated: 09/26/2026